New Age Alpha Advisors LLC Buys Shares of 11,665 Humana Inc. (NYSE:HUM)

New Age Alpha Advisors LLC acquired a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 11,665 shares of the insurance provider's stock, valued at approximately $2,960,000.

A number of other large investors have also made changes to their positions in the stock. Norges Bank bought a new stake in shares of Humana in the 4th quarter worth approximately $416,202,000. NEOS Investment Management LLC lifted its position in Humana by 27.9% in the fourth quarter. NEOS Investment Management LLC now owns 5,697 shares of the insurance provider's stock worth $1,445,000 after purchasing an additional 1,241 shares during the period. UniSuper Management Pty Ltd boosted its stake in Humana by 32.8% during the fourth quarter. UniSuper Management Pty Ltd now owns 11,227 shares of the insurance provider's stock worth $2,848,000 after buying an additional 2,770 shares in the last quarter. Artisan Partners Limited Partnership increased its holdings in Humana by 83.4% in the 4th quarter. Artisan Partners Limited Partnership now owns 673,715 shares of the insurance provider's stock valued at $170,928,000 after buying an additional 306,433 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of Humana by 9.3% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 188,793 shares of the insurance provider's stock valued at $49,552,000 after buying an additional 16,089 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Trading Down 0.0 %

Humana stock traded down $0.05 during trading hours on Tuesday, reaching $264.55. 927,232 shares of the company's stock traded hands, compared to its average volume of 1,753,344. The firm has a market capitalization of $31.93 billion, a price-to-earnings ratio of 26.59, a PEG ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The firm's 50 day moving average is $269.77 and its 200-day moving average is $273.07.

Remove Ads

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.34%. Humana's dividend payout ratio is presently 35.58%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on HUM. Royal Bank of Canada reissued an "outperform" rating and issued a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Cantor Fitzgerald reiterated a "neutral" rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Piper Sandler boosted their price target on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research note on Wednesday, January 15th. JPMorgan Chase & Co. dropped their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research note on Tuesday, February 18th. Finally, Barclays boosted their target price on shares of Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research note on Thursday, February 13th. Eighteen investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $285.68.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.